Technology use by adults with type 1 diabetes lower among African-Americans, Hispanics

Credit: CC0 Public Domain

Continuous glucose monitor (CGM) and continuous subcutaneous insulin infusion (CSII) devices are known to improve outcomes in patients with type 1 diabetes (T1D), yet African American and Hispanic patients face barriers to the use of these devices, according to results of a small single-center retrospective study. The results of the ENDO 2020 abstract will be published in the Journal of the Endocrine…

Read Entire Article Here…

Leave a Reply

Your email address will not be published. Required fields are marked *